Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Luzza

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
Medicina (Kaunas, Lithuania)|May 27, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease ProgressionLudovico Abenavoli, Anna Giulia Loricchio, Ivo Lopez, et al.
Minerva Gastroenterology|April 19, 2021
Gut microbiota and non-alcoholic fatty liver diseaseLudovico Abenavoli, Anna C Procopio, Emidio Scarpellini, et al.
Reviews on Recent Clinical Trials|June 20, 2022
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of LiteratureLudovico Abenavoli, Giulia Fabiano, Anna Caterina Procopio, et al.
Nutrients|February 6, 2021
Dietary Polyphenols and Non-Alcoholic Fatty Liver DiseaseLudovico Abenavoli, Tiziana Larussa, Alessandro Corea, et al.
Current Issues in Molecular Biology|October 28, 2025
Gut Microbiota Changes in Metabolic Dysfunction-Associated Steatohepatitis and Inflammatory Bowel Disease: Common Pathogenic FeaturesGiuseppe Guido Maria Scarlata, Domenico Morano, Abdulrahman Ismaiel, et al.
Reviews on Recent Clinical Trials|June 5, 2020
Liver Cirrhosis Complications Management at the Emergency DepartmentEmidio Scarpellini, Carmelo Luigiano, Gianluca Svegliati-Baroni, et al.
Reviews on Recent Clinical Trials|June 30, 2022
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review UpdateRocco Spagnuolo, Antonio Basile, Alessandro Corea, et al.
Obesity (Silver Spring, Md.)|February 6, 2023
Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenumTeresa Vanessa Fiorentino, Francesca De Vito, Evelina Suraci, et al.
Life (Basel, Switzerland)|October 26, 2024
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot StudyLudovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, et al.
Expert Review of Gastroenterology & Hepatology|January 25, 2015
Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver diseaseLudovico Abenavoli, Marta Greco, Immacolata Nazionale, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Medicina (Kaunas, Lithuania)|May 27, 2026
Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease ProgressionLudovico Abenavoli, Anna Giulia Loricchio, Ivo Lopez, et al.
Minerva Gastroenterology|April 19, 2021
Gut microbiota and non-alcoholic fatty liver diseaseLudovico Abenavoli, Anna C Procopio, Emidio Scarpellini, et al.
Reviews on Recent Clinical Trials|June 20, 2022
Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of LiteratureLudovico Abenavoli, Giulia Fabiano, Anna Caterina Procopio, et al.
Nutrients|February 6, 2021
Dietary Polyphenols and Non-Alcoholic Fatty Liver DiseaseLudovico Abenavoli, Tiziana Larussa, Alessandro Corea, et al.
Current Issues in Molecular Biology|October 28, 2025
Gut Microbiota Changes in Metabolic Dysfunction-Associated Steatohepatitis and Inflammatory Bowel Disease: Common Pathogenic FeaturesGiuseppe Guido Maria Scarlata, Domenico Morano, Abdulrahman Ismaiel, et al.
Reviews on Recent Clinical Trials|June 5, 2020
Liver Cirrhosis Complications Management at the Emergency DepartmentEmidio Scarpellini, Carmelo Luigiano, Gianluca Svegliati-Baroni, et al.
Reviews on Recent Clinical Trials|June 30, 2022
Measuring Mood and Anxiety Disorders by Patient Reported Outcomes in Inflammatory Bowel Disease: A Literature Review UpdateRocco Spagnuolo, Antonio Basile, Alessandro Corea, et al.
Obesity (Silver Spring, Md.)|February 6, 2023
Obesity and overweight are linked to increased sodium-glucose cotransporter 1 and glucose transporter 5 levels in duodenumTeresa Vanessa Fiorentino, Francesca De Vito, Evelina Suraci, et al.
Life (Basel, Switzerland)|October 26, 2024
Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot StudyLudovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, et al.
Expert Review of Gastroenterology & Hepatology|January 25, 2015
Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver diseaseLudovico Abenavoli, Marta Greco, Immacolata Nazionale, et al.
Pageof 16